Search for: "Ely Lilly" Results 1581 - 1600 of 2,157
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Oct 2015, 10:21 am
 Larry Welch (Eli Lilly)Larry Welch from Eli Lilly concluded the presentation by outlining the position under US law which is simple - there is no requirement to remunerate inventors under US law. [read post]
21 Sep 2020, 12:00 am by Annsley Merelle Ward
At the time of writing the full judgement is not available, yet.Immediately after the nullity hearing, Eli Lilly filed for preliminary injunctions against generics. [read post]
5 Jul 2020, 5:43 am by Annsley Merelle Ward
  On a recent celebratory birthday call, members of IP Federation (which today include BT, Dyson, GSK, Pfizer, Ocado, Arm, Microsoft, IBM, Rolls-Royce, Shell, Merck Sharp & Dohme,  Ford and Eli Lilly) shared memories of their work, triumphs and tribulations. [read post]
4 Feb 2019, 2:01 am
The new year sees the issue of yet another UK court case applying the doctrine of equivalents as established by the UK Supreme Court in Actavis v Eli Lilly ([2017] UKSC 48) ("Actavis"). [read post]
1 Jul 2017, 9:39 am
 (Eli Lilly v Novopharm (2010 FCA 197)This exercise requires:Reviewing the entire specification (claims and entire disclosure)Identifying the promises made in the entire specification Determining whether the patent fulfils those promises by demonstration or sound prediction.This exercise is a question of law viewed through the skilled person at the time of filing (with the assistance of expert evidence) and has been applied in several cases (BMS v Apotex (2005 FC 1348),… [read post]
7 Jan 2020, 7:26 am
Had the patent been valid, it would have been infringed. (3) Plausibility and SPC's The Eli Lilly v Genentech proceedings do not only relate to a (typical) patent revocation/infringement action, but also involved an issue on third-party SPC applications. [read post]
14 Dec 2009, 4:38 pm by Bruce Nye
Eli Lilly & Co. (1988) 44 Cal.3d. 1103, it starts running when the plaintiff suspects or should suspect that he or she has been wronged. . . . [read post]
10 Jun 2011, 4:09 pm
Cir. 1997) (hereinafter, Eli Lilly). [read post]
29 Jun 2006, 5:04 pm by Tony Vieira
But the combination of a new drug called pemetrexed, developed by Eli Lilly, with carboplatin could be an effective treatment for the hard-to-treat co [read post]
25 Jan 2017, 10:48 pm
 This was Andrew’s characterisation of the riddle faced by Birss J in Actavis v Eli Lilly [2016] EWHC 1955 (Pat). [read post]
2 Jun 2011, 12:46 pm by Bexis
It was the last blank space on the legal map – the only state with no precedent whatsoever. [read post]
18 Jul 2014, 11:55 am
This post is only from the Reed Smith (more properly, the non-Dechert) side of the blog.One hundred what, you say? [read post]
19 Dec 2019, 9:41 am
  In his reference, the Judge trotted through the English court's and CJEU's case law Article 3(a) - Takeda, Farmitalia, Daiichi, Yeda, Medeva (and its progeny), Actavis v Sanofi, Eli Lilly v HGS, Actavis v Boehringer, - and found that it was clear that something more was required, but what that "something" was was not clear. [read post]
28 Jul 2013, 9:29 am by Spencer Aronfeld
  Some of the other diabetes drugs being investigated include Bydureon and Onglyza, sold by Bristol-Myers Squibb; AstraZeneca and Victoza from Novo Nordisk; Tradjenta from Eli Lilly and Boehringer Ingelheim; and Nesina from Takeda. [read post]
27 Apr 2023, 9:22 am by Miquel Montañá (Clifford Chance)
In this regard, in its judgment of 12 December 2013 (case C-493/12, Eli Lilly v Human Genome Sciences), the CJEU made the following observations: “30. [read post]